Part of the pleasure of attending any large medical conference is viewing the trade exhibition. In ECCMID this year, the pharmaceutical industry is out in force but are outnumbered by the diagnostics companies. The trend continues towards point-of-care and easy to use diagnostics platforms. Next generation sequencing has not made it to prime time yet.

There is even a company that basically repackages and cells ATCC bacterial and fungal isolates, making them more compatible for other diagnostic platforms!